Page 640 - Multidisipliner Covid 19
P. 640
BÖLÜM 35
34. Yu CM, R Wong RSM, Wu EB, Kong SL, Wong J, Yip GWK, et al.Cardio
vascularcomplications of severe acuterespiratorysyndrome.Postgrad
Med J.2006; 82(964): 140–144
35. Wu CI, Postema PG, Arbelo E, Behr ER, Bezzina CR, Napolitano C,
et al.SARS-CoV-2, COVID-19 andinheritedarrhythmiasyndromes.
HearRhythm 2020. https://doi.org/10.1016/j.hrthm.2020.03.024
36. Beach SR, Celano CM, Sugrue AM, Adams C., Ackerman MJ, Nosewor-
thy PA, et al.QT Prolongation, Torsades de Pointes, andPsychotropic
Medications: A 5-Year Update Psychosomatics2018; 59(2):105-122.
37. Lee IC, Huo TI, Huang YH.GastrointestinalandLiverManifestations
in Patientswith COVID-19 J ChinMedAssoc. 2020; 83(6):521-523.
38. Xie H, Zhao J, Lian N, Lin S, Xie Q, Zhuo H. Clinicalcharacteristics of
non-ICU hospitalizedpatientswithcoronavirusdisease 2019 andliverin-
jury: A retrospectivestudy.LiverInt. 2020; 40(6):1321-1326.
39. Goldberg J, Ernst C. Managingthe Side Effects of PsychotropicMedica-
tions. 2nd Ed. Washington DC: AmericanPsychiatricAssociation Pub-
lishing; 2019: 209-244.
40. Fanelli V, Fiorentino M, Cantaluppi V, Gesualdo L, Stallone G, Ronco
C, et al.Acutekidneyinjury in SARS-CoV-2 infectedpatients.
CritCare.2020; 24(1):155.
41. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 vi-
rustargetingthe CNS: tissuedistribution, host-virusinteraction, andpro-
posedneurotropicmechanisms. ACS ChemNerosci. 2020 11(7):995-998.
42. Li YC, Bai WL,HashikawaT. Theneuroinvasivepotential of SARS-CoV2
mayplay a role in therespiratoryfailure of COVID-19 patients. J Med
Virol.2020; 92(6):552-555.
43. MaoL , Jin H, Wang M, Hu Y, Chen S, He Q, et al.Neurologicmanifes-
tations of hospitalizedpatientswithcoronavirusdisease 2019 in Wuhan,
China. JAMA 2020;77(6):683-690
44. HelmsJ , Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C,
et al.Neurologicfeatures in severe SARS-CoV-2 infection. N Engl J Med
2020; 382:2268-2270.
45. Kotfis K, RobersonSW , Wilson JE, Dabrowski W, Pun BT, Ely EW.
COVID-19: ICU deliriummanagementduring SARS-CoV-2 pandemic.
CritCare 2020; 24(1):1-9.
46. Wu CS, Wang SC, Yeh IJ, Liu SK. Comparative risk of seizurewithuse
of first- andsecond-generationantipsychotics in patientswith
639